Skip to Content

FRIDAY, 15 DECEMBER 2017, 10:20


Bumper crop of new drugs fails to lift big pharma R&D returns

Yesterday at 02:07 AM, via Reuters

LONDON (Reuters) – It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.

Ohio passes law barring abortion over Down syndrome diagnosis

Yesterday at 01:44 AM, via Reuters

CLEVELAND (Reuters) – Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.

U.S. study sheds light on how Zika causes nerve disorder

Yesterday at 01:25 AM, via Reuters

CHICAGO (Reuters) – A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.

Booze calculator

Wednesday at 21:21 PM, via BBC News

How does your drinking measure up to the average from countries around the world?

Shift work linked to burnout in sleep-deprived nurses

Wednesday at 21:00 PM, via Reuters

(Reuters Health) – Shift-work nurses who have sleep problems are more likely to experience career burnout that has the potential to compromise their job performance, a small Italian study suggests.

Music therapy may help ease depression

Wednesday at 20:58 PM, via Reuters

(Reuters Health) – Traditional depression treatments like psychotherapy or medication might work better for some patients when doctors add a dose of music therapy, a research review suggests.

Medtronic settles states’ probe into Infuse marketing for $12 million

Wednesday at 20:44 PM, via Reuters

BOSTON (Reuters) – Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

Revance will wait to seek backing for Botox-rival

Wednesday at 20:33 PM, via Reuters

(Reuters) – Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.

Obamacare sign-ups rise but overall enrollment set to fall

Wednesday at 19:47 PM, via Reuters

NEW YORK (Reuters) – The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.

Obamacare sign-ups rise to 1 million as pace picks up before deadline

Wednesday at 18:18 PM, via Reuters

NEW YORK (Reuters) – The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run website, picking up the pace ahead of the Dec. 15 deadline.

ADHD drug use in pregnancy increases risk of heart defects, study finds

Wednesday at 18:06 PM, via CNN

The attention-deficit hyperactivity disorder drug methylphenidate is associated with an increased risk of heart defects in infants whose mothers take the medication during pregnancy, according to a study published Wednesday in the journal JAMA Psychiatry.

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. ...
  8. 16